TRAIL-Cur-NPs demonstrated enhanced cellular uptake and apoptosis induction, as well as a superior therapeutic effect on xenograft HCT116 colon cancer cells in vivo compared with corresponding free drugs, without obvious toxicity [94]. Here, TNFSF10 is linked to colonic neoplasm.